Filing Details
- Accession Number:
- 0001209191-21-024233
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 18:18:37
- Reporting Period:
- 2021-03-30
- Accepted Time:
- 2021-04-01 18:18:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1807120 | Design Therapeutics Inc. | DSGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595117 | Simeon George | C/O Design Therapeutics, Inc. 6005 Hidden Valley Road, Suite 110 Carlsbad CA 92011 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-30 | 4,439,839 | $0.00 | 4,439,839 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-30 | 936,637 | $0.00 | 5,376,476 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2021-03-30 | 250,000 | $20.00 | 5,626,476 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-03-30 | 7,236,938 | $0.00 | 4,439,839 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-03-30 | 1,526,718 | $0.00 | 936,637 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
- The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
